PRIA Logo™
119-s-5059119th Congress

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Sponsored By: Senator Moody, Ashley [R-FL]

Introduced

Summary

Renumbers a part of the Public Health Service Act to streamline biosimilar reviews. It would strike subparagraph (B) of Section 351(k)(5) and redesignate the current subparagraph (C) as (B), changing statutory cross-references but not creating new deadlines, programs, funding, or eligibility rules.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Moody, Ashley [R-FL]

FL • R

Cosponsors

  • Sen. Alsobrooks, Angela D. [D-MD]

    MD • D

    Sponsored 7/21/2026

  • Sen. Scott, Rick [R-FL]

    FL • R

    Sponsored 7/21/2026

  • Sen. Blunt Rochester, Lisa [D-DE]

    DE • D

    Sponsored 7/21/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation